Impaired T cell receptor signaling in Foxp3+ CD4 T cells

Annals of the New York Academy of Sciences

Volumn 1103, Issue , 2007, Pages 167-178

  Carson, Bryan D ^a,b,c   Ziegler, Steven F ^a,b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SANDIA NATIONAL LABORATORIES   (United States)

Author keywords

Foxp3; Regulatory T cell; T cell receptor

Indexed keywords

T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 34249045721     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1394.022     Document Type: Article

References (32)

1. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182: 18-32.
2. FONTENOT, J.D., J.P. RASMUSSEN, L.M. WILLIAMS, et al. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
3. GAMBINERI, E., T.R. TORGERSON & H.D. OCHS. 2003. Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T cell homeostasis. Curr. Opin. Rheumatol. 15: 430-435.
4. + T cells. Microbes Infect. 3: 919-927.
5. GODFREY, V., J.E. WILKINSON & L.B. RUSSELL. 1991. X-linked lymphoreticular disease in the scrufy (sf ) mutant mouse. Am. J. Pathol. 138: 1379-1387.
6. + regulatory T cells. Nat. Immunol. 4: 330-336.
7. HORI, S., T. NOMURA & S. SAKAGUCHI. 2003. Control of regulatory T cell development by the transcription factor FoxP3. Science 299: 1057-1061.
8. + T regulatory cells. Nat. Immunol. 4: 337-342.
9. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
10. + regulatory T cells. J. Leuk. Biol. 80: 145-151.
11. GAVIN, M., S.R. CLARKE, E. NEGROU, et al. 2002. Homeostasis and anergy of CD4(+) CD25(+) suppressor T cells in vivo. Nat. Immunol. 2: 33-41.
12. + CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood 106: 3068-3073.
13. + regulatory T cells. J. Immunol. 177: 2186-2194.
14. KASPROWICZ, D.J., P.S. SMALLWOOD, A.J. TYZNIK & S.F. ZIEGLER. 2003. Scurfin (FoxP3) controls T-dependent immune responses in vivo through regulation of CD4+ T cell effector function. J. Immunol. 171: 1216-1223.
15. SCHUBERT, L.A., E.W. JEFFERY, Y. ZHANG, et al. 2001. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276: 37672-37679.
16. BRUNKOW, M.E., E.W. JEFFERY, K.A. HJERRILD, et al. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
17. KHATTRI, R., D.J. KASPROWICZ, T. COX, et al. 2001. The amount of scurfin protein determines peripheral T cell number and responsiveness. J. Immunol. 167: 6312-6320.
18. KASPROWICZ, D.J., N. DROIN, D.M. SOPER, et al. 2005. Dynamic regulation of FoxP3 expression controls the balance between CD4(+) T cell activation and cell death. Eur. J. Immunol. 35: 3424-3432.
19. HORI, S. & S. SAKAGUCHI. 2004. Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect. 6: 745-751.
20. BLUESTONE, J.A. & A.K. ABBAS. 2003. Natural versus adapted regulatory T cells. Nat. Rev. Immunol. 3: 253-257.
21. ZHENG, Y., S.Z. JOSEFOWICZ, A. KAS, et al. 2007. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445: 936-940.
22. MARSON, A., K. KRETSCHMER, G.M. FRAMPTON, et al. 2007. Foxp3 occupancy and regulation of key target genes during T-cell stimulation Nature 445: 931-935.
23. + T reg cells. J. Exp. Med. 203: 1701-1711.
24. BATTAGLIA, M., A. STABILINI & M.G. RONCAROLO. 2005. Rapamycin selectively expands CD4+ CD25+ FoxP3+ regulatory T cells. Blood 105: 4743-4748.
25. + regulatory T cells. Blood 107: 1018-1023.
26. + T cells. J. Immunol. 177: 944-949.
27. + regulatory T cells in renal transplant recipients Transplantation 82: 550-557.
28. BATTAGLIA, M., A. STABILINI, E. DRAGHICI, et al. 2006. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 55: 40-49.
29. SECHI, A.S. & J. WEHLAND. 2004. Interplay between TCR signaling and actin cytoskeleton dynamics. Trends Immunol. 25: 257-265.
30. FULLER, C.L., V.L. BRACIALE & L.E. SAMELSON. 2003. All roads lead to actin: the intimate relationship between TCR signaling and the cytoskeleton. Immunol. Rev. 191: 236.
31. CLEMENTS, J.L., N.J. BOERTH, J.R. LEE & G.A. KORETZKY. 1999. Integration of T cell receptor-dependent signaling pathways by adapter proteins. Annu. Rev. Immunol. 17: 89-108.
32. MILETIC, A.V., M. SWAT, K. FUJIKAWA & W. SWAT. 2003. Cytoskeletal remodeling in lymphocyte activation. Curr. Opin. Immunol. 15: 261-268.